KBC
KBC is an investment firm that provides development capital to medium-sized companies in Belgium, and Central and Eastern Europe.
Business Model:
Revenue: $8.5B
Employees: 10,001-999,999
Rankings
Industries / Tags:
Detailed KBC Information
Geographic Data
Address: Havenlaan 2
City: Brussels
State: other
Zip: 1080
Country: BE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
210,239Website Global Rank
356,188Website Monthly Traffic
Twitter Followers
Description
KBC Private Equity - the investment company of KBC Group - provides development capital and finances buy-outs to medium-sized companies in Belgium and in Central and Eastern Europe, KBC&s;s home markets. Boasting an experienced team of 28 people, it has more than 60 active investments in portfolio with a market value in excess of EUR 400 million. KBC Private Equity aims to become one of the leading private equity providers on KBC Group&s;s home markets. As an active shareholder with a long-term perspective, KBC Private Equity is involved in taking strategic decisions and providing support to management teams.
Contact Phone:
Contact Email:
KBC went public on 4/1/1999 on the EBR
Listed Exchange:
EBR
IPO Date:
4/1/1999
Ticker Symbol:
KBC
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 4/2007 | CymaBay Therapeutics | Series D | 32M |
| 6/2019 | Fnality International | Series A | 0 |
| 11/2008 | Aristo Music Technology | Venture Round | 3.4M |
| 9/2022 | Discai | Seed Round | 0 |
| 12/2020 | Stellar Labs | Pre Seed Round | 2.7M |
| 11/2016 | CitizenLab | Seed Round | 0 |
| 8/2006 | Ablynx | Series C | 50M |
| 12/2020 | Stellar Labs | Seed Round | 0 |
| 8/2017 | Joyn Belgium | Seed Round | 0 |
| 12/2004 | CymaBay Therapeutics | Series B | 44M |
| 7/2019 | ArtiQ | Seed Round | 1.1M |
| 4/2010 | Biocartis | Series B | 40M |
| 8/2022 | Setle | Seed Round | 1.5M |
| 9/2009 | arGEN-X | Series A | 13.6M |
| 6/2009 | Pronota | Series B | 7.4M |
| 11/2009 | CymaBay Therapeutics | Series E | 0 |
| 1/2012 | Pronota | Series C | 4.8M |
| 1/2007 | Movetis | Series A | 63.8M |
| 2/2010 | arGEN-X | Series A | 4.5M |
| 8/2006 | Pronota | Series A | 10.6M |
| 9/2021 | Paperspace | Series F | 0 |
| 11/2008 | Okapi Sciences | Series A | 0 |
| 6/2020 | Wizata | Series A | 3M |
| 9/2022 | Discai | Seed Round | 0 |
| 8/2022 | Setle | Seed Round | 0 |
| 9/2021 | Paperspace | Series F | 0 |
| 12/2020 | Stellar Labs | Seed Round | 0 |
| 6/2020 | Wizata | Series A | 0 |
| 7/2019 | ArtiQ | Seed Round | 0 |
| 6/2019 | Fnality International | Series A | 0 |
| 8/2017 | Joyn Belgium | Seed Round | 0 |
| 11/2016 | CitizenLab | Seed Round | 0 |
| 1/2012 | Pronota | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
